Cagrilintide Peptide: Dosage, Protocol, and Reconstitution Guide

Cagrilintide Peptide

Cagrilintide is a long-acting amylin analog studied for appetite control and weight management. It works by increasing satiety, slowing gastric emptying, and reducing overall calorie intake.

How Cagrilintide Works

Amylin Activation → Satiety ↑ → Gastric Emptying ↓ → Caloric Intake ↓ → Weight Loss

Cagrilintide mimics amylin, a hormone involved in appetite regulation. It reduces hunger signals and prolongs fullness, leading to lower food intake over time.

Cagrilintide is an amylin analog, not a GLP-1 peptide.

It mainly supports appetite control, satiety, and reduced food intake.

It is long-acting and usually discussed as a once-weekly injection.

Slow titration matters because nausea and appetite suppression can be strong.

Cagrilintide Protocol (Weekly)

10 mg vial + 3.0 mL BAC Water → 1 unit = 33.3 mcg → Weekly Appetite Support

Standard Setup

Vial10 mg

Water3.0 mL bacteriostatic water

Concentration3.33 mg/mL

Conversion1 unit = 33.3 mcg

Weeks 1–2

Start Low

Dose0.6 mg (600 mcg)

Units18 units

Volume0.18 mL

Weeks 3–4

Titration

Dose1.2 mg (1200 mcg)

Units36 units

Volume0.36 mL

Weeks 5–6

Increased Response

Dose2.4 mg (2400 mcg)

Units72 units

Volume0.72 mL

Weeks 7–16+

Maintenance

Dose4.5 mg (4500 mcg)

Units135 units

Volume1.35 mL

Protocol Details

FrequencyOnce weekly

Injection TypeSubcutaneous

Cycle Length12–16+ weeks

TitrationSlow increases every 2 weeks

Simple structure

Cagrilintide is usually discussed as a slow-titration, once-weekly appetite and satiety compound. The goal is steady appetite control without pushing too quickly into nausea or overly suppressed intake.

How to Use Cagrilintide (Timing & Injection)

Injection TypeSubcutaneous

FrequencyOnce weekly

TimingSame day each week

Common SitesAbdomen, thigh, or upper arm

Timing Notes

Inject on the same day each week for consistency.

Rotate injection sites to reduce irritation.

Can be taken with or without food.

Track appetite suppression closely during titration.

Reconstitution & Dosing (10 mg Vial)

Reconstitution & Dosing

Vial10 mg

Water3.0 mL bacteriostatic

Concentration3.33 mg/mL

Conversion1 unit = 33.3 mcg

Dose Reference

18 units = 0.6 mg (600 mcg)

36 units = 1.2 mg (1200 mcg)

72 units = 2.4 mg (2400 mcg)

135 units = 4.5 mg (4500 mcg)

Reconstitution Steps

Draw 3.0 mL bacteriostatic water

Inject slowly down vial wall

Gently swirl, do not shake

Ensure solution is fully dissolved

Protect from light

Label with the reconstitution date

Refrigerate immediately after mixing

Storage & Shelf Life

Storage & Shelf Life

Lyophilized (Unmixed Powder)

Short-term storage: keep refrigerated at 2–8°C / 36–46°F

Long-term storage: freeze at −20°C / −4°F

Estimated refrigerated shelf life: commonly ~12–24 months when sealed, dry, and protected from light

Estimated frozen shelf life: commonly up to ~2–3 years when stored properly

Keep sealed until ready to reconstitute

Protect from heat, sunlight, moisture, and repeated temperature swings

Do not repeatedly freeze and thaw the same vial

Reconstituted (Mixed)

After mixing: refrigerate at 2–8°C / 36–46°F

Best used within 30 days after reconstitution

Do not freeze after mixing

Avoid repeated temperature exposure

Discard if cloudy, discolored, or if particles appear

Best Practice

Cagrilintide should be kept cold and protected from light. Once mixed, label the vial with the date and avoid repeated warming cycles.

Cycle Length & Time Between Cycles

Appetite Control Phase → Reassess Tolerance → Continue, Pause, or Adjust

Standard Cycle Structure

Cycle Length12–16+ weeks

FrequencyOnce weekly

GoalSatiety + appetite control

TitrationSlow increases every 2 weeks

Time Between Cycles

Break2–4 weeks if cycling

Allows appetite, digestion, and intake patterns to normalize

Gives time to reassess whether weight loss is being maintained

Useful if appetite suppression becomes too strong or fatigue increases

Why reassess?

Cagrilintide can strongly reduce appetite. Reassessment helps make sure protein intake, hydration, digestion, and energy levels are staying on track.

Monitoring During Use

Appetite and fullness

Body weight and waist changes

Nausea or slowed digestion

Hydration and electrolyte intake

Protein intake and overall food volume

Fatigue, dizziness, or low intake symptoms

Benefits

Strong appetite suppression

Reduced caloric intake

Supports weight loss

Improved portion control

Long-acting, once-weekly dosing

Potential Side Effects

Nausea, most common during titration

Reduced appetite, which can be significant

Bloating or slowed digestion

Mild fatigue

Low food intake if appetite suppression is too strong

Limited long-term human data

Best Practices

Titrate slowly every 2 weeks

Inject on the same day weekly

Stay hydrated

Prioritize protein intake

Track response and tolerance

Avoid increasing the dose if nausea or appetite suppression is already too strong

Stacking Considerations

Amylin Support → Satiety ↑ → Pair Carefully With GLP-1 Pathways

Common Pairing Logic

Often paired with GLP-1 peptides in advanced protocols

May complement GLP-1 appetite and satiety signaling

Best introduced cautiously because appetite suppression can become very strong

What to Avoid

Avoid aggressive stacking initially

Avoid rapid titration when combined with other appetite-suppressing compounds

Monitor appetite suppression carefully

Do not let protein, hydration, or electrolytes fall too low

Simple rule

Cagrilintide can be very appetite-suppressive. When stacked, the goal should be controlled satiety, not food avoidance.

Important Notes

Cagrilintide is investigational and not FDA-approved

It is an amylin analog, not a GLP-1

Once-weekly dosing is commonly discussed

Slow titration helps reduce nausea and improve tolerability

Protein intake and hydration matter during appetite suppression

Long-term human data remains limited

Important Disclaimer

Cagrilintide is an investigational compound. This content is for educational purposes only.

Cagrilintide Guide → Peptide Directory →